首页> Nature medicine> Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

导出原文传递

翻译打印收藏纠错

第一作者： Jordan R,Barrett

第一单位： The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

作者： Jordan R,Barrett ^[1] ; Sandra,Belij-Rammerstorfer ^[1] ; Christina,Dold ^[2] ; Katie J,Ewer ^[1] ; Pedro M,Folegatti ^[1] ; Ciaran,Gilbride ^[1] ; Rachel,Halkerston ^[3] ; Jennifer,Hill ^[2] ; Daniel,Jenkin ^[4] ; Lisa,Stockdale ^[2] ; Marije K,Verheul ^[2] ; Parvinder K,Aley ^[2] ; Brian,Angus ^[5] ; Duncan,Bellamy ^[1] ; Eleanor,Berrie ^[6] ; Sagida,Bibi ^[2] ; Mustapha,Bittaye ^[1] ; Miles W,Carroll ^[6] ; Breeze,Cavell ^[3] ; Elizabeth A,Clutterbuck ^[2] ; Nick,Edwards ^[1] ; Amy,Flaxman ^[1] ; Michelle,Fuskova ^[1] ; Andrew,Gorringe ^[3] ; Bassam,Hallis ^[3] ; Simon,Kerridge ^[1] ; Alison M,Lawrie ^[1] ; Aline,Linder ^[2] ; Xinxue,Liu ^[2] ; Meera,Madhavan ^[1] ; Rebecca,Makinson ^[1] ; Jack,Mellors ^[3] ; Angela,Minassian ^[1] ; Maria,Moore ^[2] ; Yama,Mujadidi ^[2] ; Emma,Plested ^[2] ; Ian,Poulton ^[1] ; Maheshi N,Ramasamy ^[2] ; Hannah,Robinson ^[2] ; Christine S,Rollier ^[2] ; Rinn,Song ^[2] ; Matthew D,Snape ^[2] ; Richard,Tarrant ^[6] ; Stephen,Taylor ^[3] ; Kelly M,Thomas ^[3] ; Merryn,Voysey ^[2] ; Marion E E,Watson ^[1] ; Daniel,Wright ^[1] ; Alexander D,Douglas ^[1] ; Catherine M,Green ^[6] ; Adrian V S,Hill ^[1] ; Teresa,Lambe ^[1] ; Sarah,Gilbert ^[1] ; Andrew J,Pollard ^[7] ; Oxford COVID Vaccine Trial Group

作者单位： The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. ^[1] Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. ^[2] Public Health England, Salisbury, UK. ^[3] The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Daniel.Jenkin@ndm.ox.ac.uk. ^[4] Nuffield Department of Medicine, University of Oxford, Oxford, UK. ^[5] Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. ^[6] Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.Pollard@paediatrics.ox.ac.uk. ^[7]